FDA Inspection 1204455 — Anand K. Ganesan, M.D., Ph.D.
The FDA completed an inspection of Anand K. Ganesan, M.D., Ph.D. on April 26, 2023 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 26, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Irvine, CA (United States)
Additional Details
Clinical Investigator (CI)